Nina Helbekkmo

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

Nina Helbekkmo, Stein Sundstrøm, Ulf Aasebø et al. · British Journal of Cancer · 2007 · 77 citations · Full text

Medicine, Oncology, Pharmacology +16

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm et al. · British Journal of Cancer · 2013 · 65 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016

Odd Terje Brustugun, Bjørn Henning Grønberg, Lars Fjellbirkeland et al. · Lung Cancer · 2018 · 38 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

Bridging the distance: a prospective tele-oncology study in Northern Norway

Tom Dønnem, Bente Ervik, Kathrine Magnussen et al. · Supportive Care in Cancer · 2011 · 34 citations

Medicine, Oncology, Medical Oncology +3

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial

Hans H. Strøm, Roy M. Bremnes, Stein Sundstrøm et al. · Journal of Thoracic Oncology · 2014 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +17